Subscribe to Newsletter

Search

Reset Filter

4110 search results for ‘*’

Business & Regulation Standards & Regulation

The Underworld of Counterfeit Fentanyl

| Jamie Irvine | 6 min read

A deep dive into the dangers of fentanyl entering the US supply chain – and the importance of the Drug Supply Chain Security Act

Manufacture Vaccines

The Shadow of COVID-19

| Stephanie Vine | 10 min read

How the European Commission has struck deals to secure manufacturing capacity for future emergencies.

Manufacture Facilities

Uniting a Cell and Gene Kingdom

| Jamie Irvine | 2 min read

Exploring the ins and outs of a recent UK-based collaboration between two prominent advanced medicine players

Business & Regulation Profession

Roundtable Discussion: Women in Pharma

What can the pharma industry do about the glass ceiling in women’s careers?

Manufacture Advanced Medicine

Reactions to the UK’s Approval of a CRISPR Medicine

| Stephanie Vine | 3 min read

Scientists celebrate a new era of genetic medicine but what do we do about the costs?

Manufacture Bioprocessing - Upstream & Downstream

The Case for MMC

| Heidi Jones | 8 min read

The use of multimodal chromatography is increasing in biopharma purification processes. Here’s why.

Discovery & Development Drug Discovery

Minds, Interrupted

| Ashlea Segal, Alex Fornito | 2 min read

Researchers develop a new approach to mapping the individual heterogeneity of brain changes in mental disorders

Discovery & Development Drug Discovery

A Chip Off the New Block

| Tomasz Kostrzewski | 3 min read

In vivo animal models have brought much to the science behind the drug development industry, but how far behind are organ-on-a-chip models?

Manufacture Advanced Medicine

Putting the “Go” in Oligonucleotide Manufacturing

| Ben Pellegrini | 3 min read

Intellegens CEO Ben Pellegrini explains how machine learning is set to change the oligonucleotide manufacturing landscape

Manufacture Advanced Medicine

The World’s First CRISPR-Based Therapeutic Approval

| Stephanie Vine | 3 min read

It’s official: CRISPR medicines are here as UK authorizes exa-cel.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register